The University of North Carolina at Chapel Hill has been awarded a five-year $54.6 million Clinical and Translational Science Award (CTSA) from the National Institutes of Health. With the award, UNC-CH will partner with two institutions, RTI International and North Carolina Agricultural and Technical State University, to accelerate the pace at which clinical and translational research directly benefits patients and communities in North Carolina.
The grant is NIH’s second to support the North Carolina Translational and Clinical Sciences (NC TraCS) Institute. The project is expanding to include RTI International as a research partner and N.C. A&T as a planning partner.
The partnership with A&T will give UNC researchers access to the state-of-the-art laboratories at the Joint School of Nanoscience and Nanoengineering, while providing NC A&T faculty collaborative opportunities and financial resources to accelerate discoveries in the lab to patients, particularly those from underrepresented minorities.
“Together, we will develop a robust pipeline of minority clinical and translational research scientists in a manner that can be a model for the nation,” said Barry L. Burks, N.C. A&T’s Vice Chancellor for Research and Economic Development.
The institutions will focus on three strategic initiatives: